What is LOPJLB’s current signal on CTOR?

LOPJLB’s latest quantitative signal on Citius Oncology, Inc. (CTOR) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CTOR in?

Citius Oncology, Inc. (CTOR) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Citius Oncology, Inc. (CTOR) do?

Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New Yo…

Where is Citius Oncology, Inc. based / listed?

Citius Oncology, Inc. is based in US, listed on NASDAQ.

Citius Oncology, Inc. (CTOR)

COMPARE

Healthcare · Medical - Pharmaceuticals · NASDAQ · US

$0.84+1.20%Close

SELLCRISIS · day 6

[SCORES & PROFILE]

FUND: 28
VALUE: 17
GROWTH: 10
GARP: 87
TYPE: Growth Compounder

Composite of Value · Growth · GARP

ROIC-61.8%

REV YoY-

ROE-103.0%

EPS YoY-

ROA-41.1%

GROSS

-666

NET

-648

[VALUATION]

P/E TTM-1.78

P/E FWD9.62

SECTOR PE20.47

INDUSTRY PE108.47

P/B2.27

P/FCF-

EV/EBITDA-1.69

EV/EBIT-

PEG0.12

FCF YIELD-

RISK

INT COV-

D/E25.28

ALTMAN Z-

CURR RATIO0.73

ND/EBITDA-

BETA3.53

Citius Oncology, Inc. (CTOR)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news